HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

formalinized extracellular antigen

isolated from melanoma cells; used to immunize mice against challenge with melanoma cells

Also Known As:

fECA (antigen)

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Biological Factors: 2472
- Antigens: 143924
  - Neoplasm Antigens: 6217
    - formalinized extracellular antigen: 2

Related Diseases

1.	Melanoma (Melanoma, Malignant) 07/01/1996 - "The immunodominant component of a formalinized extracellular antigen (fECA) vaccine prepared from B16 F10 melanoma cells is the melanoma-associated antigen B700. " 05/01/1995 - "Preimmunization of mice with a formalinized extracellular antigen vaccine, derived from B16 F10 melanoma cells, provided partial inhibition of the growth of the primary melanoma tumors, as well as reducing the number of metastases to the regional (inguinal) lymph nodes and lungs along with concomitantly increasing survival time. "
2.	Neoplasms (Cancer) 05/01/1995 - "Preimmunization of mice with a formalinized extracellular antigen vaccine, derived from B16 F10 melanoma cells, provided partial inhibition of the growth of the primary melanoma tumors, as well as reducing the number of metastases to the regional (inguinal) lymph nodes and lungs along with concomitantly increasing survival time. "
3.	Neoplasm Metastasis (Metastasis) 05/01/1995 - "Preimmunization of mice with a formalinized extracellular antigen vaccine, derived from B16 F10 melanoma cells, provided partial inhibition of the growth of the primary melanoma tumors, as well as reducing the number of metastases to the regional (inguinal) lymph nodes and lungs along with concomitantly increasing survival time. "

Related Drugs and Biologics

1.	Vaccines
2.	Antigens